Skip to main content

Table 1 Sample characteristics at baseline: controls, patients with active and inactive psoriasis

From: Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire

 

Patients (active psoriasis)N = 182

Patients (inactive psoriasis)N = 122

Controls N = 56

P**

Socio-demographic variables

Age, mean (SD), years

43.6 (14.7)

47.8 (14.0)

38.8 (14.0)

<0.01

Male, n (%)

101 (55.5)

70 (57.4)

29 (51.8)

0.54

Highest educational level, n (%)

   

<0.01

No formal education

5 (2.8)

4 (3.3)

4 (7.1)

 

Primary

66 (36.9)

46 (38.0)

11 (19.6)

 

Secondary

62 (34.6)

45 (37.2)

15 (26.8)

 

Post-secondary

46 (25.7)

26 (21.5)

26 (46.4)

 

Employment status, n (%)

   

<0.05

Unemployed

19 (10.4)

12 (9.8)

6 (10.7)

 

Working – self-employed

26 (14.3)

11 (9.0)

10 (17.9)

 

Working – employed

87 (47.8)

59 (48.4)

28 (50.0)

 

Work disability

1 (0.5)

4 (3.3)

1 (1.8)

 

Pensioner/retired

19 (10.4)

25 (20.5)

3 (5.4)

 

Looking after home

22 (12.1)

9 (7.4)

7 (12.5)

 

Student

9 (4.9)

5 (4.1)

7 (12.5)

 

Clinical variables

Years since diagnosis, mean (SD)

18.6 (12.4)

17.8 (11.9)

 

NS

PASI, n (%)

   

<0.01

Mild (<10)

31 (17.0%)

98 (80.3%)

  

Moderate/severe ≥ 10

151 (83.0%)

24 (19.7%)

  

Treatment*

    

Any

177 (97.3%)

104 (85.2%)

 

<0.01

Topical

90 (49.5%)

44 (36.1%)

 

<0.05

PUVA/Phototherapy

25 (13.7%)

10 (8.2%)

 

NS

Systemic

101(55.5%)

54 (44.3%)

 

NS

Biological

57 (31.3%)

59 (48.4%)

 

<0.01

Other

32 (17.6%)

9 (7.4%)

 

0.01

  1. PASI: Psoriasis Area Severity Index.
  2. *Multi-response. The same patient could be in more than one category. Calculation performed for N = 304 (all patients).
  3. **Statistically significant differences between patients and controls in proportion of Pensioners/retired.